Autres langues PREDILIFE

Actions

ALPRE

FR0010169920

Temps réel Euronext Paris Autres places de cotation 13:12:36 02/05/2024			Varia. 5j.	Varia. 1 janv.
21,6 ^EUR	+319,42 %		+424,27 %	+278,95 %

28/03	Predilife : en hausse après la progression de son activité en 2023	AO
07/03	Le retour de Boucle d'or

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Predilife : IN EXTENSO FINANCE UPDATES COVERAGE ON PREDILIFE STOCK; TARGET PRICE OF EUR 25.07 REPRESENTS +391% POTENTIAL UPSIDE	01/05
Predilife : Valuation of MammoRisk(R) software	25/04
Predilife : un projet labellisé par Finance Innovation	04/09/23
Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	15/07/23
Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23
Predilife : contrat avec Colas pour un bilan prédictif	12/04/23
Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	28/10/22
Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	25/04/22
Predilife Taps Eurofins to Conduct Genetic Testing of Saliva Samples	20/12/21
Global markets live: Valneva, Glencore, Facebook, Roche, Hertz...	18/10/21
Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	28/09/21
Global markets live: Valneva,Boeing, Facebook, Kubota, Otis...	23/09/21
Global markets live: Credit Suisse, Apple, Verizon...	03/05/21
EN DIRECT DES MARCHES : Credit Suisse, KPN, Apple, DBV, Carbios, Verizon, Siemens Healthineers, AB Science...	03/05/21
Biden ressort son carnet de chèques	31/03/21
EN DIRECT DES MARCHES : Capgemini, Total, Eramet, Casino, Visiomed, Bayer, Wells Fargo, Volkswagen, Illumina...	31/03/21
PrediLife : and the Institut Curie Announce a Partnership Covering Genetic Analyses for MammoRisk®, the Next-Generation Test Predicting the Risk of Breast Cancer	06/05/19
Predilife S.A. and Institut Curie Announce Partnership Covering Genetic Analyses for Mammorisk, the Next-Generation Test Predicting the Risk of Breast Cancer	06/05/19
Predilife S.A. has completed an IPO in the amount of €3.591232 million.	18/12/18
Predilife S.A. has filed an IPO in the amount of €7.006296 million.	04/12/18

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PREDILIFE

Actions

ALPRE

FR0010169920

Autres langues

Filtres